University of Texas Health San Antonio
Disclosure: Astellas (Grant/Research Support)BioMerieux (Grant/Research Support)Cepheid (Grant/Research Support)Covance (Grant/Research Support)F2G (Grant/Research Support)Gilead (Speaker's Bureau)Mayne Pharma (Advisor or Review Panel member)Sfunga (Grant/Research Support)
Dr. Wiederhold’s research is focused on trends in antifungal resistance, new mechanisms of drug resistance in fungi, and the evaluation of novel agents under development for the treatment of invasive fungal infections, concentrating on the preclinical evaluation of investigational therapeutic modalities and diagnostic technologies for the diagnosis and treatment of fungal infections. This includes both in vitro assessment for activity against a wide range of fungal pathogens, such as multi-drug resistant clinical isolates, and in vivo models of invasive fungal infections. Dr. Wiederhold is also director of the Fungus Testing Laboratory in the Department of Pathology and Laboratory Medicine at UT Health San Antonio. This is an mycology reference laboratory that performs clinical testing on specimens from insitutions across the U.S.